Proteomics International Laboratories Ltd

ASX:PIQ Stock Report

Market Cap: AU$83.8m

Proteomics International Laboratories Future Growth

Future criteria checks 2/6

Proteomics International Laboratories is forecast to grow earnings and revenue by 28.8% and 40.2% per annum respectively while EPS is expected to grow by 36.6% per annum.

Key information

28.8%

Earnings growth rate

36.6%

EPS growth rate

Life Sciences earnings growth20.4%
Revenue growth rate40.2%
Future return on equityn/a
Analyst coverage

Low

Last updated11 Sep 2024

Recent future growth updates

Recent updates

Most Shareholders Will Probably Find That The CEO Compensation For Proteomics International Laboratories Limited (ASX:PIQ) Is Reasonable

Nov 16
Most Shareholders Will Probably Find That The CEO Compensation For Proteomics International Laboratories Limited (ASX:PIQ) Is Reasonable

Calculating The Fair Value Of Proteomics International Laboratories Limited (ASX:PIQ)

Sep 29
Calculating The Fair Value Of Proteomics International Laboratories Limited (ASX:PIQ)

We're Hopeful That Proteomics International Laboratories (ASX:PIQ) Will Use Its Cash Wisely

May 10
We're Hopeful That Proteomics International Laboratories (ASX:PIQ) Will Use Its Cash Wisely

Here's Why We Think Proteomics International Laboratories Limited's (ASX:PIQ) CEO Compensation Looks Fair for the time being

Nov 17
Here's Why We Think Proteomics International Laboratories Limited's (ASX:PIQ) CEO Compensation Looks Fair for the time being

Is Proteomics International Laboratories (ASX:PIQ) In A Good Position To Invest In Growth?

Aug 09
Is Proteomics International Laboratories (ASX:PIQ) In A Good Position To Invest In Growth?

Earnings and Revenue Growth Forecasts

ASX:PIQ - Analysts future estimates and past financials data (AUD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/202710-2-2-11
6/30/20266-5-5-51
6/30/20253-8-7-61
6/30/20243-6-6-6N/A
3/31/20243-6-6-5N/A
12/31/20233-6-6-5N/A
9/30/20233-6-6-5N/A
6/30/20233-6-7-6N/A
3/31/20233-6-6-5N/A
12/31/20224-6-5-4N/A
9/30/20223-5-4-4N/A
6/30/20223-5-4-4N/A
3/31/20223-5-3-3N/A
12/31/20213-4-3-3N/A
9/30/20213-4-3-3N/A
6/30/20213-3-2-2N/A
3/31/20213-3-1-1N/A
12/31/20202-200N/A
9/30/20203-2-10N/A
6/30/20203-2-20N/A
3/31/20203-2-3-1N/A
12/31/20193-2-3-2N/A
9/30/20193-2-2-2N/A
6/30/20193-2-2-2N/A
3/31/20193-2-2-2N/A
12/31/20183-2-1-1N/A
9/30/20182-2-1-1N/A
6/30/20182-1-1-1N/A
3/31/20182-1N/A-1N/A
12/31/20172-1N/A-1N/A
9/30/20172-1N/A-1N/A
6/30/20172-1N/A-1N/A
3/31/20172-1N/A-1N/A
12/31/20162-1N/A-1N/A
9/30/20162-1N/A-1N/A
6/30/20161-1N/A-2N/A
3/31/20161-2N/A-1N/A
12/31/20151-2N/A-1N/A
9/30/20151-2N/A-1N/A
6/30/20151-1N/A-1N/A
6/30/201410N/A0N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: PIQ is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: PIQ is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: PIQ is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: PIQ's revenue (40.2% per year) is forecast to grow faster than the Australian market (5.8% per year).

High Growth Revenue: PIQ's revenue (40.2% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if PIQ's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 23:28
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Proteomics International Laboratories Ltd is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Iain WilkieMorgans Financial Limited